Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • Sbamo
    Junior Member
    • Jan 2016
    • 7

    #1

    Should discordant pairs be used for counting/DGE?

    Hello everyone,

    I am using the STAR aligner, which reports discordant pair alignments in a seperate BAM file. Using my workflow I want to search for differentially expressed genes, transcripts and exons.

    My question:
    - Should I calculate feature counts using only the concordant pairs or include the discordant pairs for counting?

    Note that I am examining samples for patients with leukaemia, where gene fusions are common events and have been detected in my samples using other methods. There are around 100000-500000 pairs (out of ~30 million) reported as discordantly aligned.

    I am afraid that including discordant pairs will introduce a bias in calculating gene expression. Excluding them, on the other hand, could also introduce a bias. Any and all ideas are welcome! Thanks!

Latest Articles

Collapse

  • SEQadmin2
    16S/ITS Profiling vs. Shotgun Metagenomics: What Changes in Your Workflow?
    by SEQadmin2




    NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection...
    10-30-2026, 06:46 AM
  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-28-2026, 09:57 AM
0 responses
41 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-28-2026, 09:51 AM
0 responses
25 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 11:13 AM
0 responses
74 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 10:48 AM
0 responses
48 views
0 reactions
Last Post SEQadmin2  
Working...